[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @sanofi Sanofi Sanofi posts on X about regeneron, the first the most. They currently have XXXXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::35846368/interactions)  - X Week XXX -XX% - X Month XXXXX -XX% - X Months XXXXXX +168% - X Year XXXXXX -XX% ### Mentions: X [#](/creator/twitter::35846368/posts_active)  - X Month X -XX% - X Months XX +153% - X Year XX -XX% ### Followers: XXXXXXX [#](/creator/twitter::35846368/followers)  - X Week XXXXXXX -XXXX% - X Month XXXXXXX -XXXX% - X Months XXXXXXX -XXXX% - X Year XXXXXXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::35846368/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) **Social topic influence** [regeneron](/topic/regeneron), [the first](/topic/the-first) **Top accounts mentioned or mentioned by** [@mikej_ha_ha](/creator/undefined) [@grok](/creator/undefined) [@regeneron](/creator/undefined) [@paris2024](/creator/undefined) [@usfda](/creator/undefined) [@emanews](/creator/undefined) [@garyselfcare](/creator/undefined) [@oranomed](/creator/undefined) [@sanofipasteur](/creator/undefined) [@translatebio](/creator/undefined) [@openaito](/creator/undefined) [@fda](/creator/undefined) [@eucommission](/creator/undefined) [@read_magazine21](/creator/undefined) [@klln349312](/creator/undefined) [@businessatoecd](/creator/undefined) [@time](/creator/undefined) [@gsk](/creator/undefined) [@lancetrespirmed](/creator/undefined) [@thelancet](/creator/undefined) ### Top Social Posts Top posts by engagements in the last XX hours "At #ACAAI25 were presenting phase X results in allergic fungal rhinosinusitis (AFRS) in people aged X years and older underscoring our commitment to advancing care for chronic respiratory diseases. CC: @Regeneron" [X Link](https://x.com/sanofi/status/1986782226772529278) 2025-11-07T13:06Z 146.2K followers, 1323 engagements "The European Commission has approved our medicine in the EU for certain adults and adolescents with moderate-to-severe chronic spontaneous urticaria (CSU) marking the first targeted treatment option in over a decade. Read more CC: @Regeneron" [X Link](https://x.com/sanofi/status/1993324285021372756) 2025-11-25T14:21Z 146.2K followers, 1172 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@sanofi SanofiSanofi posts on X about regeneron, the first the most. They currently have XXXXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks
Social topic influence regeneron, the first
Top accounts mentioned or mentioned by @mikej_ha_ha @grok @regeneron @paris2024 @usfda @emanews @garyselfcare @oranomed @sanofipasteur @translatebio @openaito @fda @eucommission @read_magazine21 @klln349312 @businessatoecd @time @gsk @lancetrespirmed @thelancet
Top posts by engagements in the last XX hours
"At #ACAAI25 were presenting phase X results in allergic fungal rhinosinusitis (AFRS) in people aged X years and older underscoring our commitment to advancing care for chronic respiratory diseases. CC: @Regeneron"
X Link 2025-11-07T13:06Z 146.2K followers, 1323 engagements
"The European Commission has approved our medicine in the EU for certain adults and adolescents with moderate-to-severe chronic spontaneous urticaria (CSU) marking the first targeted treatment option in over a decade. Read more CC: @Regeneron"
X Link 2025-11-25T14:21Z 146.2K followers, 1172 engagements
/creator/twitter::sanofi